New device could offer stroke prevention without blood thinners for heart patients
Disease control
Ongoing
This study is testing a device called the Omega™ LAA Occluder in 200 people with non-valvular atrial fibrillation who are at high risk for bleeding. The device is implanted to seal off the left atrial appendage, a small pouch in the heart where clots often form. The goal is to re…
Phase: NA • Sponsor: Eclipse Medical Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC